Diaceutics plc logo

Diaceutics plc (DXRX)

Market Open
7 Aug, 15:30
LSE LSE
153. 00
GBX
+3.5
+2.3411%
GBX
115.48M Market Cap
- P/E Ratio
- Div Yield
80,724 Volume
- Eps
149.5 GBX
Previous Close
Add Transaction
Day Range
149 155
Year Range
125 180
Want to track DXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DXRX trading today higher at 153 GBX, an increase of 2.3411% from yesterday's close, completing a monthly increase of 6.6202% or 9.5 GBX. Over the past 12 months, DXRX stock gained 20.9486%.
DXRX is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

DXRX Chart

People also search for

HSP
Hargreaves Services Plc
796 GBX
-0.2506%
SEE
Seeing Machines Limited
4.75 GBX
+3.7118%
SUP
Supreme Plc
142 GBX
+3.6496%
SOM
Somero Enterprises, Inc.
232.5 GBX
0%
CNS
China Steel Corporation Sponsored GDR
8.75 GBX
0%

Diaceutics plc (DXRX) FAQ

What is the stock price today?

The current price is 153.00 GBX.

On which exchange is it traded?

Diaceutics plc is listed on LSE.

What is its stock symbol?

The ticker symbol is DXRX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 115.48M.

Has Diaceutics plc ever had a stock split?

No, there has never been a stock split.

Diaceutics plc Profile

Professional Services Industry
Industrials Sector
Ryan Keeling CEO
LSE Exchange
GB00BJQTGV64 ISIN
GB Country
205 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Diaceutics PLC is a pioneering company in the realm of diagnostic commercialisation, delivering comprehensive data, analytics, and implementation services to pharmaceutical enterprises globally. Its foundation was laid in 2005, and since then, it has established its headquarters in Belfast, United Kingdom. The cornerstone of its innovation is the DXRX platform, a multifaceted ecosystem designed to streamline the pathway of precision medicine diagnostics by fostering collaboration among labs, pharmaceutical, and diagnostic companies. This platform not only facilitates access to an extensive range of diagnostic testing data but also propels the commercialisation and development processes of therapeutics and companion diagnostics. Through its services, Diaceutics PLC aims to bridge the gaps in the precision medicine marketplace, ensuring that patients receive timely and accurate diagnoses to guide their treatment options effectively.

Products and Services

Diaceutics PLC offers a comprehensive suite of products and services designed to address various facets of precision medicine diagnostics:

  • DXRX Data Solutions: These include access to a wide array of diagnostic testing data from a network of laboratories. Key offerings under this category are:
    • DXRX Signal: Provides insights and analytics from laboratory data to identify trends and opportunities.
    • Lab Mapping: A service that maps out laboratory capabilities and testing availability worldwide.
    • Testing Dashboard: Offers real-time monitoring of testing volumes and patterns.
    • Physician Mapping: Assists in identifying and connecting with physicians knowledgeable about specific biomarkers and testing.
  • DXRX Marketplace Solutions: Facilitates a dynamic marketplace for labs, pharmaceutical companies, and diagnostic companies to find collaborators for precision medicine diagnostics projects.
  • DXRX Lab Education: A collection of tailored training sessions for laboratories, focusing on enhancing testing quality and biomarker knowledge to support precision diagnostics.
  • DXRX Advisory Boards: Provides pharmaceutical companies with platforms to engage with experts, gaining new insights into the commercialisation and development of therapies or companion diagnostics.
  • DXRX Lab Alerts: This advanced service delivers targeted, educational messages to laboratories in the DXRX network, fostering awareness and action on essential diagnostics practices.
  • Implementation and Consulting Services: Offers specialized support for the execution and advisory needs concerning precision medicine diagnostics, ensuring the alignment of diagnostic strategies with overall therapeutic goals.

Contact Information

Address: Building Two
Phone: +44 28 9042 8133